a. Staffing Update

b. Job Descriptions

c. License Applications

5) Staff Recommendations on Final Licenses

a. Alternative Therapies Group, Inc. (# MR281255), Retail

b. I.N.S.A., Inc. (# MC281268), Cultivation, Tier 7-Indoor

c. I.N.S.A., Inc. (# MP281426), Product Manufacturer

d. I.N.S.A., Inc. (# MR281680), Retail

6) Staff Recommendations on Provisional License Applications

a. 1620 Labs, LLC (# MCN281370), Cultivation, Tier 1-Indoor

b. 1620 Labs, LLC (# MPN281418), Product Manufacturer

c. Atlantic Medicinal Partners, Inc. (# MCN281476), Cultivation, Tier 2-Indoor

d. Atlantic Medicinal Partners, Inc. (# MPN281360), Product Manufacturer

e. Atlantic Medicinal Partners, Inc. (# MRN281471), Retail

f. Good Chemistry of Massachusetts, Inc. (# MCN281557), Cultivation, Tier 4-Indoor

g. Good Chemistry of Massachusetts, Inc. (# MPN281410), Retail

h. Good Chemistry of Massachusetts, Inc. (# MRN281702), Retail

i. Revolutionary Clinics II, Inc. (# MCN281507), Cultivation, Tier 8-Indoor

j. Revolutionary Clinics II, Inc. (# MPN281425), Product Manufacturer

k. Sanctuary Medicinals, Inc. (# MRN281650), Retailer

l. T. Bear, Inc. (# MPN281314), Product Manufacturer

7) Commission Discussion and Votes

a. Policy Discussion of Draft Regulations on Medical Use of Marijuana (935 CMR 501.000) and Colocation Adult-Use and Medical Use Marijuana Operations (935 CMR 502.000)

b. Guidance on Tinctures

c. Open Data RFR

8) New Business that the Chairman did not anticipate at time of posting

9) Next Meeting Date

Notice of Executive Session

Under the Open Meeting Law, G.L. c. 30A, § 21(a)(4) and (7) and the Public Records Law, G.L. c. 66, and the exemptions set forth in G.L. c. 4, § 7(26)(a), (f) and (n), the Commission may enter into executive session on the following agenda items: